Genetic Variants Linked to Severe Form of Muscular Dystrophy
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchResearchers from Perth’s Harry Perkins Institute of Medical Research have led a study that uncovered changes in a gene associated with a rare and severe form of muscular dystrophy. The…
Gene Mutation Discovery Sheds Light on Rare Muscle Disorder
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchA groundbreaking study led by Dr Mridul Johari and Associate Professor Gina Ravenscroft, has identified that a genetic mutation is responsible for a rare and debilitating form of congenital myopathy.…
Perkins researchers discover muscle disease gene
By Richard Schoonraad | Genes, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, News & Events, ResearchResearchers at the Harry Perkins Institute of Medical Research and The University of Western Australia (UWA) have discovered the genetic cause of a rare muscle disease that causes muscle weakness,…
Perkins Represented in Premiers Science Awards
By Richard Schoonraad | Antibiotic diagnostics, awards, BioDiscovery, Community, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Lungs, Media Releases, News & Events, ResearchThree celebrated scientists from WA’s Harry Perkins Institute of Medical Research, have been named as finalists in the 2024 Premier’s Science Awards. Associate Professor Gina Ravenscroft, Dr Kieran Mulroney and…
Buckle up as WA’s Premier Truck Show announces HUGE money raised for Cancer Research!
By Richard Schoonraad | Cancer, Community Events, Events, Funding, Fundraising, Media Releases, News & Events, Supporters$500,000 donated to the Harry Perkins Institute of Medical Research in Perth to drive cutting-edge cancer research! Last night the WA Mack Muster and Truck Show team and their sponsors…
1000 walkers raise over $1.45m for women’s cancer research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Disease Area, Events, Fundraising, News & Events, Ovarian CancerTaking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…